Dashboard Settings
Dark Mode
Time Period
About Elevance Health Inc.
Ticker: ELV
Exchange: NYSE
Sector: Healthcare
Industry: Managed Healthcare
Headquarters: Indianapolis, Indiana
Data source: Refinitiv • MSN • Analyst reports
Anthem (ELV) Stock Price, Financials, P/E ratio: Buy or Wait?
Last price: $439.81 ▲ +3.44 (0.79%) • Market Cap: $99.57B
Market Cap
$99.57B
P/E Ratio
17.17x
-18.90x vs Peers
Dividend Yield
1.56%
$6.84 per share
Stock Price Chart
Valuation Metrics
Valuation Analysis:
- ELV is trading at a P/E multiple (17.17x) below peer average (36.07x)
- P/S ratio of 0.57x vs industry average 1.27x
- Price/Book ratio of 2.46x vs industry average -0.71x
- EV/EBITDA ratio of 25.93x (industry average)
Earnings & Revenue
EPS QoQ Growth
-54.12%
EPS YoY Growth
-31.67%
+59.46% vs Peers
Revenue QoQ Growth
+0.60%
Revenue YoY Growth
+5.97%
-1.10% vs Peers
Future Growth Forecasts
EPS YoY Forecast
+5.33%
vs Peer Average
-2.45%
vs Industry Average
-2.86%
Revenue YoY Forecast
+9.24%
vs Peer Average
-2.09%
vs Industry Average
+1.09%
Financial Health
Financial Health Analysis:
- Debt to Equity ratio: 75.59% (peer average 81.33%)
- Return on Equity: 14.83% (peer average 15.58%)
- Net Profit Margin: 3.38% (peer average 3.36%)
- Quick Ratio: Insufficient data for comparison
Profitability Metrics
Analyst Recommendations
Analyst Consensus
- Rating: Strong Buy (based on 22 analysts)
- 12-month price target: $507.81
- Potential upside: 15.4% from current price
Key Analyst Insights
- P/S and P/E multiples below industry averages
- Revenue growth forecasted above industry average
- Debt position better than peers
- EPS declines offset by improved net margins